Sullivan Christopher Ryan

CIK 00018104171 companyROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001810417

Recent Transactions

17 trades

Tax Payment
Avalo Therapeutics, Inc.$AVTX
Common Stock
2025-12-10$4.10/sh−155→ 17,338 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Restricted Stock Units
2025-03-28−24,200→ 48,400 total
Exercise/Conversion
Avalo Therapeutics, Inc.$AVTX
Common Stock
2025-03-28+24,200→ 24,206 total
Tax Payment
Avalo Therapeutics, Inc.$AVTX
Common Stock
2025-03-28$8.46/sh−7,285→ 16,921 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2025-01-28+163,000→ 163,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2024-08-13+186,700→ 186,700 total
Award
Avalo Therapeutics, Inc.$AVTX
Restricted Stock Units
2024-08-13+72,600→ 72,600 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2023-06-09$3.42/sh+511→ 1,262 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2023-05-15+40,000→ 40,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2023-02-13+40,000→ 40,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-10-05+25,000→ 25,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-03-08+400,000→ 400,000 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2022-03-08+50,000→ 50,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2021-12-10$1.57/sh+955→ 9,004 total
Award
Avalo Therapeutics, Inc.$AVTX
Stock Option (Right to Buy)
2021-01-26+110,000→ 110,000 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2020-12-10$2.28/sh+5,095→ 8,049 total
Purchase
Avalo Therapeutics, Inc.$AVTX
Common Stock
2020-06-10$2.28/sh+2,954→ 2,954 total

Companies

Avalo Therapeutics, Inc.
Chief Financial Officer
$AVTX

Recent Filings

Address

C/O AVALO THERAPEUTICS, INC. 540 GAITHER ROAD, SUITE 400

ROCKVILLE, MD, 20850

View on SEC.gov